FDA NDC Directory · JSON-LD · Markdown
NDC 0143-9240 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Labeler / Manufacturer | Hikma Pharmaceuticals USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA065042 |
| Dosage form / route | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRAPLEURAL INTRAVENOUS SUBCUTANEOUS |
| Active ingredients | BLEOMYCIN SULFATE (15 [USP'U]/1) |
| Marketing started | 20180109 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).